Annual CFI
$105.54 M
+$233.91 M+182.21%
31 December 2023
Summary:
Intra-Cellular Therapies annual cash flow from investing activities is currently $105.54 million, with the most recent change of +$233.91 million (+182.21%) on 31 December 2023. During the last 3 years, it has risen by +$585.84 million (+121.97%). ITCI annual CFI is now -62.35% below its all-time high of $280.34 million, reached on 31 December 2021.ITCI Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$209.20 M
-$216.97 M-2793.83%
30 September 2024
Summary:
Intra-Cellular Therapies quarterly cash flow from investing activities is currently -$209.20 million, with the most recent change of -$216.97 million (-2793.83%) on 30 September 2024. Over the past year, it has dropped by -$189.04 million (-937.35%). ITCI quarterly CFI is now -279.93% below its all-time high of $116.27 million, reached on 31 March 2021.ITCI Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$137.84 M
-$189.04 M-369.21%
30 September 2024
Summary:
Intra-Cellular Therapies TTM cash flow from investing activities is currently -$137.84 million, with the most recent change of -$189.04 million (-369.21%) on 30 September 2024. Over the past year, it has dropped by -$246.22 million (-227.18%). ITCI TTM CFI is now -149.17% below its all-time high of $280.34 million, reached on 31 December 2021.ITCI TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +182.2% | -937.4% | -227.2% |
| 3 y3 years | +122.0% | -428.1% | -362.6% |
| 5 y5 years | -21.6% | -619.9% | -189.6% |
ITCI Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -62.4% | +122.0% | -297.1% | +35.0% | -149.2% | +18.7% |
| 5 y | 5 years | -62.4% | +122.0% | -279.9% | +35.0% | -149.2% | +71.3% |
| alltime | all time | -62.4% | +122.0% | -279.9% | +35.0% | -149.2% | +71.3% |
Intra-Cellular Therapies Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$209.20 M(-2793.8%) | -$137.84 M(-369.2%) |
| June 2024 | - | $7.77 M(-52.0%) | $51.20 M(-62.9%) |
| Mar 2024 | - | $16.18 M(-65.9%) | $138.18 M(+30.9%) |
| Dec 2023 | $105.54 M(-182.2%) | $47.42 M(-335.1%) | $105.54 M(-2.6%) |
| Sept 2023 | - | -$20.17 M(-121.3%) | $108.38 M(-53.8%) |
| June 2023 | - | $94.75 M(-675.6%) | $234.72 M(+32.5%) |
| Mar 2023 | - | -$16.46 M(-132.8%) | $177.20 M(-238.0%) |
| Dec 2022 | -$128.37 M(-145.8%) | $50.26 M(-52.7%) | -$128.37 M(+1.0%) |
| Sept 2022 | - | $106.17 M(+185.2%) | -$127.13 M(-25.0%) |
| June 2022 | - | $37.23 M(-111.6%) | -$169.53 M(+7.3%) |
| Mar 2022 | - | -$322.04 M(-725.2%) | -$157.96 M(-156.3%) |
| Dec 2021 | $280.34 M(-158.4%) | $51.51 M(-19.2%) | $280.34 M(+434.0%) |
| Sept 2021 | - | $63.77 M(+30.7%) | $52.50 M(-134.0%) |
| June 2021 | - | $48.79 M(-58.0%) | -$154.49 M(-26.8%) |
| Mar 2021 | - | $116.27 M(-165.9%) | -$211.04 M(-56.1%) |
| Dec 2020 | -$480.30 M(-370.7%) | -$176.34 M(+23.1%) | -$480.30 M(+80.4%) |
| Sept 2020 | - | -$143.22 M(+1746.1%) | -$266.22 M(+221.6%) |
| June 2020 | - | -$7.76 M(-94.9%) | -$82.77 M(+307.9%) |
| Mar 2020 | - | -$152.98 M(-505.4%) | -$20.29 M(-111.4%) |
| Dec 2019 | $177.44 M | $37.74 M(-6.2%) | $177.44 M(+15.3%) |
| Sept 2019 | - | $40.24 M(-26.5%) | $153.85 M(+8.4%) |
| June 2019 | - | $54.72 M(+22.3%) | $141.87 M(+22.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $44.74 M(+216.3%) | $116.11 M(-13.8%) |
| Dec 2018 | $134.64 M(-245.2%) | $14.15 M(-49.9%) | $134.64 M(-528.9%) |
| Sept 2018 | - | $28.26 M(-2.4%) | -$31.39 M(+39.6%) |
| June 2018 | - | $28.95 M(-54.2%) | -$22.49 M(+9.3%) |
| Mar 2018 | - | $63.28 M(-141.7%) | -$20.57 M(-77.8%) |
| Dec 2017 | -$92.72 M(-200.5%) | -$151.88 M(-508.7%) | -$92.72 M(-252.4%) |
| Sept 2017 | - | $37.16 M(+20.4%) | $60.84 M(-20.6%) |
| June 2017 | - | $30.87 M(-448.1%) | $76.65 M(+3.8%) |
| Mar 2017 | - | -$8.87 M(-628.9%) | $73.82 M(-20.0%) |
| Dec 2016 | $92.26 M(-125.5%) | $1.68 M(-96.8%) | $92.26 M(-157.5%) |
| Sept 2016 | - | $52.97 M(+88.9%) | -$160.35 M(-38.1%) |
| June 2016 | - | $28.05 M(+193.1%) | -$258.91 M(-9.3%) |
| Mar 2016 | - | $9.57 M(-103.8%) | -$285.51 M(-21.1%) |
| Dec 2015 | -$361.78 M(+442.1%) | -$250.94 M(+450.5%) | -$361.78 M(+222.2%) |
| Sept 2015 | - | -$45.58 M(-3250.7%) | -$112.29 M(+32.8%) |
| June 2015 | - | $1.45 M(-102.2%) | -$84.54 M(-36.6%) |
| Mar 2015 | - | -$66.70 M(+4507.3%) | -$133.44 M(+100.0%) |
| Dec 2014 | -$66.73 M(-4650.0%) | -$1.45 M(-91.9%) | -$66.73 M(+2.2%) |
| Sept 2014 | - | -$17.83 M(-62.4%) | -$65.29 M(+37.6%) |
| June 2014 | - | -$47.45 M(>+9900.0%) | -$47.45 M(>+9900.0%) |
| Mar 2014 | - | -$3100.00 | -$3100.00 |
| Dec 2013 | $1.47 M(-74.1%) | - | - |
| Dec 2012 | $5.66 M | - | - |
FAQ
- What is Intra-Cellular Therapies annual cash flow from investing activities?
- What is the all time high annual CFI for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual CFI year-on-year change?
- What is Intra-Cellular Therapies quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly CFI year-on-year change?
- What is Intra-Cellular Therapies TTM cash flow from investing activities?
- What is the all time high TTM CFI for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies TTM CFI year-on-year change?
What is Intra-Cellular Therapies annual cash flow from investing activities?
The current annual CFI of ITCI is $105.54 M
What is the all time high annual CFI for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual cash flow from investing activities is $280.34 M
What is Intra-Cellular Therapies annual CFI year-on-year change?
Over the past year, ITCI annual cash flow from investing activities has changed by +$233.91 M (+182.21%)
What is Intra-Cellular Therapies quarterly cash flow from investing activities?
The current quarterly CFI of ITCI is -$209.20 M
What is the all time high quarterly CFI for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly cash flow from investing activities is $116.27 M
What is Intra-Cellular Therapies quarterly CFI year-on-year change?
Over the past year, ITCI quarterly cash flow from investing activities has changed by -$189.04 M (-937.35%)
What is Intra-Cellular Therapies TTM cash flow from investing activities?
The current TTM CFI of ITCI is -$137.84 M
What is the all time high TTM CFI for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high TTM cash flow from investing activities is $280.34 M
What is Intra-Cellular Therapies TTM CFI year-on-year change?
Over the past year, ITCI TTM cash flow from investing activities has changed by -$246.22 M (-227.18%)